ClinicalTrials.gg
CompletedNCT02641886Updated Jul 19, 2019

The Study of Jian Pi Yi Shen Hua Tan Granules in Cognitive Impairment After Acute Cerebral Infarction

An interventional study of Jian Pi Yi Shen Hua Tan Granules and the placebo group in Cognitive Impairment, sponsored by Dongfang Hospital Beijing University of Chinese Medicine. Completed at 5 sites in China. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2019-07-19.

Sponsored by Dongfang Hospital Beijing University of Chinese Medicine · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
40 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 310 studies in Cognitive Dysfunction with a site in China — 144 open to participants now, 156 under way, 8 of them phase 3. Cognitive Dysfunction · China.

Enrollment
35th of 191
300 · median 110
Started
2016
with 8 others
No phase
139 of 310
61 open now
Registered
24th of 310
by date

Among the 310 studies in Cognitive Dysfunction with a site in China, this one is the 35th largest by enrollment of the 191 interventional ones that give a count, is one of 9 that started in 2016, is one of 139 with no phase, and was the 24th registered.

Cognitive Dysfunction

3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.

Browse Cognitive Dysfunction studies →

Open to participants now

144 of the 310 studies in Cognitive Dysfunction with a site in China are open now. Recruiting first, the newest first:

139 more — sign in →

All 144 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.

This study: 40 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 310 studies in Cognitive Dysfunction with a site in China, or all of them as a file.
02

Study summary

The purpose of this study is to determine whether the chinese medicine Jian Pi Yi Shen Hua Tan granules is effective in the treatment of cognitive impairment after acute cerebral infarction .

Read the detailed description

The present study is designed to observe the symptoms,syndrome characteristics and neuropsychological changes of patients with cognitive dysfunction after Acute Cerebral Infarction, as well as study the patterns of syndrome evolution and neuropsychological characteristics, in order to provide evidences for the early-stage identification, diagnosis, intervention and treatment based on syndrome differentiation.

To assess the effectiveness of applying early-stage prevention on patients with cognitive impairment after Acute Cerebral Infarction through the use of traditional Chinese medicine--Jian Pi Yi Shen Hua Tan granules, explore the pathogenesis and therapeutic efficacy mechanism, evaluate the effectiveness of early-stage prevention and provide alternative solutions for preventing or delaying dementia.

03

Conditions studied

  • Cognitive Impairment

Keywords

  • traditional Chinese medicine granules
  • Cognitive Impairment
  • Acute cerebral infraction
  • prevention
04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients conform to the diagnostic criteria of acute ischemic stroke Online Certificate Status Protocol classification of cerebral infarction : Partial Anterior Circulation Infarct, Posterior Circulation Infarct or Lacunar Infarction - Stroke onset within 14 days
  • Neuropsychological assessments: Scale scores less than 26 points or scores less than 27 points,MMSE scores range from 19 points to 26 points
  • Age from forty to eighty, gender not limited
  • Informed and signed the

Exclusion criteria

Exclusion Criteria:

  • Online Certificate Status Protocol classification of cerebral infarction is a total anterior circulation infarction
  • Stroke patients with the causes of cerebral hemorrhage, subarachnoid hemorrhage, brain tumors, brain injury, or blood diseases and so on.
  • Stroke with an onset of more than 14 days
  • Cerebral embolism caused by atrial fibrillation resulted from rheumatic heart disease, coronary heart disease and other heart diseases.
  • Patients who cannot cooperate with the check due to serious visual, hearing dysfunction, apraxia, aphasia.
  • Patients with other neurological diseases which can affect cognitive function (for example: severe Parkinson's disease, normal pressure hydrocephalus, brain tumors, encephalitis)
  • Patients with communication difficulties, or psychiatric disease
  • Depression (Hamilton Depression Scale scores more than or equal to 17 points) Diagnosed with alcohol or drug dependence within the past six months
  • With other diseases which can cause cognitive dysfunction, Such as thyroid dysfunction, severe anemia, syphilis, and so on
  • With a previous history of stroke and serious sequelae, and cannot cope with neuropsychological examination
  • With severe primary diseases, and cannot comply with the above scheme
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

TIA (transient ischaemic attack)

A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.

Stroke symptoms need emergency care at once, even if they go away.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
300 participants (actual)

Study arms

  • Experimental
    Jian Pi Yi Shen Hua Tan Granules group

    Treat with the prescription of Jianpi Yishen Huatan Granules and conventional treatment of ischemic stroke.

    Drug: Jian Pi Yi Shen Hua Tan Granules

  • Placebo comparator
    the Placebo Group

    Treat with the placebo which contain 5% of prescription of Jian Pi Yi Shen Hua Tan Granules and 95% dextrin and conventional treatment of ischemic stroke.

    Other: the placebo group

Interventions

  • DrugJian Pi Yi Shen Hua Tan Granules

    Jianpi Yishen Huatan Granules contain Herba cistanche,Fructus Alpinia Oxyphyllae,Rhodiola rosea, Polygala tenuifolia willd and Coptis chinensis.Jianpi Yishen Huatan Granules dissolved in water of 100 ml ,po, bid of each 90-days cycle. Number of treatment cycles: one

    Also known as: Jianpi Yishen Huatan Granules group

  • Otherthe placebo group

    Treat with the placebo which contain 5% of prescription of Jian Pi Yi Shen Hua Tan Granules and 95% dextrin.The placebo dissolved in water of 100 ml ,po, bid of each 90-days cycle. Number of cycles: one

06

What researchers measure

Primary outcomes

  1. mini-mental state examination

    Using mini-mental state examination to examine the patients' cognitive function

    Time frame: 90 days

  2. Montreal Cognitive Assessment scale

    Using Montreal Cognitive Assessment scale to examine the patients' cognitive function

    Time frame: 90 days

  3. Stroop test

    Using Stroop test to examine executive function and attention

    Time frame: 90 days

  4. Numerical sequence test(DS-S)

    Using Numerical sequence test(DS-S) to examine memeory

    Time frame: 90 days

  5. Digital color connection test (CCT)

    Using Numerical sequence test(DS-S) to examine executive function and attention

    Time frame: 90 days

  6. Verbal memory test(HVLT)

    Using Verbal memory test(HVLT) to examine verbal memory

    Time frame: 90 days

Secondary outcomes

  1. national institute of health stroke scale

    Using national institute of health stroke scale to examine the neurologic function impairment

    Time frame: 90 days

  2. modified Rankin scale

    Using modified Rankin scale to examine the recovery of neurologic function

    Time frame: 90 days

  3. Activity of Daily Living Scale

    Using Activity of Daily Living Scale to examine daily living ability

    Time frame: 90 days

  4. scores of Chinese medicine symptoms

    Using the scores of Chinese medicine symptoms to examine the Chinese medicine syndrom

    Time frame: 90 days

07

Study locations

5 sites
  • Department of Neurology,Dongfang Hospital
    Beijing, Beijing 100078, China
  • Shunyi Hospital of Traditional Chinese Medicine
    Beijing, Beijing 101300, China
  • Chongqing Hospital of Traditional Chinese Medicine
    Chongqing, Chongqing 400011, China
  • Jiangmen Wuyi Hospital of Traditional Chinese Medicine
    Jiangmen, Guangdong 529000, China
  • the Affiliated Hospital to Changchun University of Chinese Medicine
    Changchun, Jilin 130103, China
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2016 to primary completion in Jan 2019, 34 months.

Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's 34 months is above that.

Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 13, 2015
First posted
Dec 30, 2015
StartActual
Mar 9, 2016
Primary completionActual
Jan 18, 2019
CompletionActual
Apr 18, 2019
Last update
Jul 19, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 19, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02641886
Lead sponsor
Dongfang Hospital Beijing University of Chinese Medicine
Collaborators
Changchun University of Chinese Medicine, Chongqing Traditional Chinese Medicine Hospital, Jiangmen Wuyi Hospital of Traditional Chinese Medicine, Shunyi Hospital of Traditional Chinese Medicine
Responsible party
Yunling Zhang (President of Dongfang Hospital, Dongfang Hospital Beijing University of Chinese Medicine) — Principal investigator
First posted
Dec 30, 2015
Start date
Mar 9, 2016
Primary completion
Jan 18, 2019
Completion
Apr 18, 2019
Last update
Jul 19, 2019

Study contacts

Yunling Zhang, PhD,MD
study chair · Dongfang Hospital Beijing University of Chinese Medicine

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion